2-Chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 66716507, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][C:18]1[CH:19]=[N:20][N:21]([CH:23]2[CH2:28][CH2:27][N:26]([CH3:29])[CH2:25][CH2:24]2)[CH:22]=1.[Cl:30][C:31]1[CH:36]=[C:35](B2OC(C)(C)C(C)(C)O2)[CH:34]=[C:33]([F:46])[C:32]=1[OH:47]>>[Cl:30][C:31]1[CH:36]=[C:35]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12]([CH:14]2[CH2:15][CH2:16]2)=[O:13])=[C:5]3[NH:17][C:18]2[CH:19]=[N:20][N:21]([CH:23]3[CH2:24][CH2:25][N:26]([CH3:29])[CH2:27][CH2:28]3)[CH:22]=2)[CH:34]=[C:33]([F:46])[C:32]=1[OH:47]Participants
3
Procedure
Following general procedure D, (6-bromo-4-(1-(1-methylpiperidin-4-yl)-1H-pyrazol-4-ylamino)quinolin-3-yl)(cyclopropyl)methanone (50 mg, 0.11 mmol) was reacted with 2-chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (47 mg, 0.17 mmol) to afford the desired product (35 mg, 59%) as a yellow-green solid: 1H NMR (500 MHz, CD3OD+TFA-d) δ 9.94 (s, 1H), 8.24 (m, 1H), 8.02 (m, 2H), 7.68 (s, 1H), 7.22 (s, 2H), 4.62 (t, J=5.3 Hz, 1H), 3.69 (d, J=12.7 Hz, 2H), 3.50 (s, 1H), 3.25 (m, 2H), 2.95 (s, 3H), 2.39 (m, 4H), 1.24 (m, 4H); ESI MS m/z 520 [C28H27ClFN5O2+H]+; HPLC 99.5% (AUC), tR=10.37 min.
Sources & evidence
- ORD record
- ord-9b59adf003904f39b4ff8390c0c1f693
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…